Rapid Decrease in Pruritus With Ruxolitinib Cream for Patients With Atopic Dermatitis: Pooled Results From TRuE-AD1 and TRuE-AD2

From Clinical Care Options (CCO) and Dr. Robert Sidbury, expert commentary on new data in atopic dermatitis evaluation and management.

Robert Sidbury, MD, MPH Released: June 30, 2021

Assessment of depth, rapidity of response of abrocitinib and dupilumab in patients with moderate to severe AD in JADE COMPARE using stringent endpoints: atopic dermatitis conference coverage from Clinical Care Options (CCO)

Characterization of skin pain in children with atopic dermatitis: atopic dermatitis conference coverage from Clinical Care Options (CCO)

Analysis of efficacy of oral azoles as a potential treatment for dupilumab facial redness: atopic dermatitis conference coverage from Clinical Care Options (CCO)